(Q33638719)

28 July 2017

title

Novel peptidyl aryl vinyl sulfones as highly potent and selective inhibitors of cathepsins L and B. (English)

1 reference

28 July 2017

Meritxell Teixidó

4

0 references

Ernest Giralt i Lledó

object named as

Ernest Giralt

series ordinal

8

1 reference

28 July 2017

7

Albert Moyano

1 reference

28 July 2017

3

Teresa Tarragó

1 reference

28 July 2017

1

Laura Mendieta

1 reference

28 July 2017

Anna Picó

2

1 reference

28 July 2017

Marcos Castillo

series ordinal

5

1 reference

28 July 2017

Llorenç Rafecas

series ordinal

6

1 reference

28 July 2017

publication date

1 September 2010

1 reference

28 July 2017

1 reference

28 July 2017

volume

5

1 reference

28 July 2017

issue

9

1 reference

28 July 2017

page(s)

1556-1567

1 reference

Quantification of cathepsins B and L in cells

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000109

Multiple roles for cysteine cathepsins in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000109

Degradation of extracellular-matrix proteins by human cathepsin B from normal and tumour tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000109

Peptidyl vinyl sulphones: a new class of potent and selective cysteine protease inhibitors: S2P2 specificity of human cathepsin O2 in comparison with cathepsins S and L.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000109

Cysteine peptidases of mammals: their biological roles and potential effects in the oral cavity and other tissues in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000109

7 January 2021

Human and parasitic papain-like cysteine proteases: their role in physiology and pathology and recent developments in inhibitor design.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000109

7 January 2021

Aziridide-Based Inhibitors of Cathepsin L: Synthesis, Inhibition Activity, and Docking Studies

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000109

7 January 2021

Cathepsin expression during skeletal development

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000109

7 January 2021

Cysteine cathepsin proteases as pharmacological targets in cancer

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000109

7 January 2021

Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000109

7 January 2021

Inhibition of tumour cell invasion by protease inhibitors: correlation with the protease profile

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000109

7 January 2021

Distinct roles for cysteine cathepsin genes in multistage tumorigenesis

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000109

7 January 2021

Inhibition of cysteine cathepsin protease activity enhances chemotherapy regimens by decreasing tumor growth and invasiveness in a mouse model of multistage cancer

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000109

7 January 2021

Synthesis of peptide aldehyde derivatives as selective inhibitors of human cathepsin L and their inhibitory effect on bone resorption

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000109

7 January 2021

Design and synthesis of dual inhibitors for matrix metalloproteinase and cathepsin.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000109

7 January 2021

Novel, nonpeptidic cyanamides as potent and reversible inhibitors of human cathepsins K and L.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000109

7 January 2021

Identification of dipeptidyl nitriles as potent and selective inhibitors of cathepsin B through structure-based drug design

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000109

7 January 2021

Vinyl sulfones as mechanism-based cysteine protease inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000109

7 January 2021

Toxoplasma gondii Cathepsin L Is the Primary Target of the Invasion-inhibitory Compound Morpholinurea-leucyl-homophenyl-vinyl Sulfone Phenyl

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000109

7 January 2021

Cysteine protease inhibitors as chemotherapy for parasitic infections

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000109

7 January 2021

Cysteine protease inhibitors cure an experimental Trypanosoma cruzi infection

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000109

7 January 2021

Specificity determinants of human cathepsin s revealed by crystal structures of complexes

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000109

7 January 2021

Crystal structure of human cathepsin K complexed with a potent inhibitor

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000109

7 January 2021

Enantiodivergent, catalytic asymmetric synthesis of gamma-amino vinyl sulfones

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000109

7 January 2021

Development of peptidomimetics with a vinyl sulfone warhead as irreversible falcipain-2 inhibitors.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000109

7 January 2021

Peptidyl allyl sulfones: a new class of inhibitors for clan CA cysteine proteases

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000109

7 January 2021

1,2-dioxines containing tethered hydroxyl functionality as convenient precursors for pyran syntheses

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000109

7 January 2021

Identification by 19F NMR of traditional Chinese medicinal plants possessing prolyl oligopeptidase inhibitory activity

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000109

7 January 2021

Distributed automated docking of flexible ligands to proteins: Parallel applications of AutoDock 2.4

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000109

7 January 2021

The crystal structure of human cathepsin F and its implications for the development of novel immunomodulators

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000109

7 January 2021

The refined 2.15 A X-ray crystal structure of human liver cathepsin B: the structural basis for its specificity

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000109

7 January 2021

Identifiers

DOI

10.1002/CMDC.201000109

1 reference

release_2nf3i43dsrgilgtmwguxn6bvxi

28 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2nf3i43dsrgilgtmwguxn6bvxi

24 November 2022

mapped directly with Wikidata item

1 reference